Vimarsana
Biggest News Aggregation in the World

Page 2 - Circulatory Support Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Circulatory Support Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Circulatory Support Program Today - Breaking & Trending Today

InvestmentPitch Media Video Di - GuruFocus.com - Vimarsana News

InvestmentPitch Media Video Di - GuruFocus.com

GuruFocus Article or News written by Stock market mentor and the topic is about:

Hemostemix Inc.: Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation - Vimarsana News

Hemostemix Inc.: Hemostemix Announces Letter of Commitment, Non-Dilutive Funding Structure and $250,000 of Funding by the McGill University Health Centre Foundation

Calgary, Alberta--(Newsfile Corp. - January 19, 2023) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it has received a $250,000 Letter of Commitment

Hemostemix Inc.: Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials - Vimarsana News

Hemostemix Inc.: Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials

Calgary, Alberta--(Newsfile Corp. - October 26, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce Dr. Giannetti and Dr. Cecere as Co-Lead

Hemostemix Inc.: Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board - Vimarsana News

Hemostemix Inc.: Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board

Calgary, Alberta--(Newsfile Corp. - September 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Renzo Cecere, MD, FRCSC

CARMAT Announces a New Commercial Implant of Its Aeson Artificial Heart at University Medical Center Schleswig-holstein in Kiel, Germany - Vimarsana News

CARMAT Announces a New Commercial Implant of Its Aeson Artificial Heart at University Medical Center Schleswig-holstein in Kiel, Germany

Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people